Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rituximab is a safe and effective alternative treatment for patients with autoimmune hepatitis: Results from the ColHai registry.
Riveiro-Barciela M, Barreira-Díaz A, Esteban P, Rota R, Álvarez-Navascúes C, Pérez-Medrano I, Mateos B, Gómez E, De-la-Cruz G, Ferre-Aracil C, Horta D, Díaz-González Á, Ampuero J, Díaz-Fontenla F, Salcedo M, Ruiz-Cobo JC, Londoño MC. Riveiro-Barciela M, et al. Among authors: alvarez navascues c. Liver Int. 2024 Sep;44(9):2303-2314. doi: 10.1111/liv.15970. Epub 2024 May 29. Liver Int. 2024. PMID: 38809086
Evaluation of cardiovascular events in patients with hepatocellular carcinoma treated with sorafenib in the clinical practice. The CARDIO-SOR study.
Carballo-Folgoso L, Álvarez-Velasco R, Lorca R, Castaño-García A, Cuevas J, González-Diéguez ML, Martín M, Álvarez-Navascués C, Cadahía V, Morís C, Rodríguez M, Varela M. Carballo-Folgoso L, et al. Liver Int. 2021 Sep;41(9):2200-2211. doi: 10.1111/liv.14941. Epub 2021 May 26. Liver Int. 2021. PMID: 33966333
Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study.
Reig A, Álvarez-Navascués C, Vergara M, Gómez-Domínguez E, Gallego-Moya A, Pérez-Medrano IM, Fábrega E, Hernández-Guerra M, Berenguer M, Estevez P, Arencibia A, Morillas RM, Horta D, Albillos A, Casado M, De la Cruz G, Fernandez-Bonilla E, Molina E, Hijona L, Diago M, Fernández-Rodriguez CM, González-Santiago JM, Sala M, Gómez-Camarero J, Romero-Gomez M, Suárez F, Vargas V, Ferre-Aracil C, Andrade RJ, Chahri N, Parés A. Reig A, et al. Among authors: alvarez navascues c. Am J Gastroenterol. 2021 Nov 1;116(11):2250-2257. doi: 10.14309/ajg.0000000000001343. Am J Gastroenterol. 2021. PMID: 34158466
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration.
Díaz-González Á, Hernández-Guerra M, Pérez-Medrano I, Sapena V, Riveiro-Barciela M, Barreira-Díaz A, Gómez E, Morillas RM, Del Barrio M, Escudé L, Mateos B, Horta D, Gómez J, Conde I, Ferre-Aracil C, El Hajra I, Arencibía A, Zamora J, Fernández A, Salcedo M, Molina E, Soria A, Estévez P, López C, Álvarez-Navascúes C, García-Retortillo M, Crespo J, Londoño MC; ColHai Registry. Díaz-González Á, et al. Among authors: alvarez navascues c. Hepatology. 2023 Apr 1;77(4):1095-1105. doi: 10.1097/HEP.0000000000000018. Epub 2023 Jan 3. Hepatology. 2023. PMID: 36626622 Free article.
Multidrug-resistant bacterial infections after liver transplantation: Prevalence, impact, and risk factors.
Martin-Mateos R, Martínez-Arenas L, Carvalho-Gomes Á, Aceituno L, Cadahía V, Salcedo M, Arias A, Lorente S, Odriozola A, Zamora J, Blanes M, Len Ó, Benítez L, Campos-Varela I, González-Diéguez ML, Lázaro DR, Fortún J, Cuadrado A, Carrasco NM, Rodríguez-Perálvarez M, Álvarez-Navascues C, Fábrega E, Serrano T, Cuervas-Mons V, Rodríguez M, Castells L, Berenguer M, Graus J, Albillos A. Martin-Mateos R, et al. Among authors: alvarez navascues c. J Hepatol. 2024 Jun;80(6):904-912. doi: 10.1016/j.jhep.2024.02.023. Epub 2024 Feb 28. J Hepatol. 2024. PMID: 38428641
Clinical and genetic factors involved in Porto-sinusoidal vascular disorder after oxaliplatin exposure.
Puente A, Fortea JI, Del Pozo C, Serrano M, Alonso-Peña M, Giráldez A, Tellez L, Martinez J, Magaz M, Ibañez L, Garcia J, Llop E, Alvarez-Navascues C, Romero M, Rodriguez E, Arias Loste MT, Antón A, Echavarria V, López C, Albillos A, Hernández-Gea V, Garcia-Pagán JC, Bañares R, Crespo J; by REHEVASC group. Puente A, et al. Among authors: alvarez navascues c. Dig Liver Dis. 2024 Oct;56(10):1721-1729. doi: 10.1016/j.dld.2024.04.010. Epub 2024 May 7. Dig Liver Dis. 2024. PMID: 38719628
Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome.
Magaz M, Giudicelli-Lett H, Nicoară-Farcău O, Rajoriya N, Goel A, Raymenants K, Hillaire S, Crespo G, Téllez L, Elkrief L, Fondevila C, Orts L, Nery F, Shukla A, Larrue H, Fundora Y, Degroote H, Aguilera V, LLop E, Turco L, Indulti F, Gioia S, Tosetti G, Bitto N, Becchetti C, Alvarado E, Roig C, Diaz R, Praktiknjo M, Konicek AL, Soy G, Olivas P, Fortea JI, Masnou H, Puente Á, Ardèvol A, Álvarez-Navascués C, Romero M, Scheiner B, Semmler G, Mandorfer M, Damião F, Baiges A, Turon F, Simón-Talero M, González-Alayón C, Díaz A, García-Criado Á, de Gottardi A, Reverter E, Blasi A, Genescà J, Roux O, Francoz C, Noronha Ferreira C, Reiberger T, Rodríguez M, Morillas RM, Crespo J, Trebicka J, Bañares R, Villanueva C, Berzigotti A, Primignani M, La Mura V, Riggio O, Schepis F, Procopet B, Verhelst X, Calleja JL, Bureau C, Albillos A, Nevens F, Hernández-Gea V, Tripathi D, Rautou PE, Durand F, García-Pagán JC. Magaz M, et al. Among authors: alvarez navascues c. Transplantation. 2023 Jun 1;107(6):1330-1340. doi: 10.1097/TP.0000000000004444. Epub 2023 May 23. Transplantation. 2023. PMID: 36479977
Impact of SARS-CoV-2 vaccination in patients with vascular liver diseases: Observations from a VALDIG multicenter study.
Perez-Campuzano V, Rautou PE, Marjot T, Praktiknjo M, Alvarado-Tapias E, Turco L, Ibáñez-Samaniego L, González-Alayón C, Puente Á, Llop E, Simón-Talero M, Álvarez-Navascués C, Reiberger T, Verhelst X, Tellez L, Bergmann JB, Orts L, Grassi G, Baiges A, Audrey P, Trebicka J, Villanueva C, Morelli MC, Murray S, Meacham G, Luetgehetmann M, Schulze Zur Wiesch J, García-Pagán JC, Barnes E, Plessier A, Hernández-Gea V; ERN RARE-LIVER; a study of VALDIG, an EASL consortium and REHEVASC. Perez-Campuzano V, et al. Among authors: alvarez navascues c. JHEP Rep. 2024 Aug 22;6(12):101191. doi: 10.1016/j.jhepr.2024.101191. eCollection 2024 Dec. JHEP Rep. 2024. PMID: 39583091 Free PMC article.
23 results